NEW YORK (GenomeWeb News) – Synamatix, a bioinformatics company based in Kuala Lumpur, said today that Premas Biotech will serve as its distributor in India, Bangladesh, and in Sri Lanka.

Synamatix said that Premas is the exclusive distributor for Illumina's Genome Analyzer in India, which gives it "the added advantage of understanding the requirements of the diverse scientific community in South Asia."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.